Cell-free DNA promoter hypermethylation as a diagnostic marker for pancreatic ductal adenocarcinoma – An external validation study
Open Access
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Pancreatology
- Vol. 21 (6) , 1081-1091
Abstract
No abstract availableKeywords
Funding Information
- Aalborg University Hospital
This publication has 30 references indexed in Scilit:
- Novel Methylation Biomarker Panel for the Early Detection of Pancreatic CancerClinical Cancer Research, 2013
- CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative TherapyAnnals of Surgical Oncology, 2012
- High recovery of cell-free methylated DNA based on a rapid bisulfite-treatment protocolBMC Molecular Biology, 2012
- The Role of Quantitative NPTX2 Hypermethylation as a Novel Serum Diagnostic Marker in Pancreatic CancerPancreas, 2012
- Cell-free nucleic acids as biomarkers in cancer patientsNature Reviews Cancer, 2011
- Epigenetic Silencing of Tumor Suppressor Genes in Pancreatic CancerJournal of Gastrointestinal Cancer, 2011
- Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detectionBest Practice & Research Clinical Gastroenterology, 2010
- CpG island methylation profile of pancreatic intraepithelial neoplasiaLaboratory Investigation, 2007
- K-ras Mutation and p16 and Preproenkephalin Promoter Hypermethylation in Plasma DNA of Pancreatic Cancer PatientsPancreas, 2007
- Circulating Nucleic Acids in Plasma and SerumAnnals of the New York Academy of Sciences, 2006